Abstract Objective To assess the efficacy of golimumab (GLM) as a treatment option for juvenile idiopathic arthritis (JIA)-associated uveitis refractory to adalimumab (ADA). Methods Retrospective single-centre study including patients with JIA receiving GLM for active uveitis after failing ADA. JIA- and uveitis-related data. including intraocular inflammation. https://www.bekindtopets.com/discount-Ancient-Roman-Gladiator-Murmillo-Cassis-Crista-Helmet-With-Medieval-Style-Skullcap-Nasal-Helmets-With-Nose-Guard-3-Re-big-savings/